- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
- 10-K Annual report
- 1.1 Capital on Demandtm Sales Agreement, Dated December 21, 2022 Between Neuroone Medical Technologies Corporation. and Jonestrading Institutional Services LLC
- 5.1 Opinion of Honigman LLP
- 21.1 Subsidiaries of the Registrant
- 23.1 Consent of Baker Tilly Us, LLP
- 31.1 Certification
- 31.2 Certification
- 32.1 Certification
- 32.2 Certification
- Download Excel data file
- View Excel data file
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statements on Form S-1 (File No. 333-232656, 333-2444487, 333-252951), Form S-3 (File No. 333-256830) and Form S-8 (File No. 333-224572, 333-261302, 333-262397) of NeuroOne Medical Technologies Corporation of our report dated December 21, 2022, relating to the financial statements, which report expresses an unqualified opinion on the financial statements for the year eneded September 30, 2022 and includes an explanatory paragraph relating to the Company’s ability to continue as a going concern as described in Note 2 to the financial statements, appearing herein.
/s/ BAKER TILLY US, LLP
Minneapolis, Minnesota
December 21, 2022